U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Livestock Investors Inc Ltd - 04/22/2015
  1. Warning Letters

WARNING LETTER

Livestock Investors Inc Ltd

Product:
Animal & Veterinary

Recipient:
Livestock Investors Inc Ltd


United States

Issuing Office:
Dallas District Office

United States


   

Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
  Dallas District Office
4040 North Central Expressway
Suite 300
Dallas, Texas 75204-3128 

 

April 22, 2015
 
2015-DAL-WL-17
 
WARNING LETTER
 
UPS Overnight
                                                                                                     
 
Johnny E. Trotter, Owner/General Manager
275 FM 1057
Summerfield, Texas 79045
 
Dear Mr. Trotter:
 
On February 2 through 5, 2015, the U.S. Food and Drug Administration (FDA) conducted an investigation of your feedlot operation located at 275 FM 1057, Summerfield, Texas 79045. This letter notifies you of the violations of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) that we found during our investigation of your operation. You can find the FD&C Act and its associated regulations on the Internet through links on FDA’s web page at www.fda.gov
 
We found that you offered for sale an animal for slaughter as food that was adulterated. Under section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. § 342(a)(2)(C)(ii), a food is deemed to be adulterated if it bears or contains a new animal drug that is unsafe under section 512 of the FD&C Act, 21 U.S.C. § 360b. Further, under section 402(a)(4) of the FD&C Act, 21 U.S.C. § 342(a)(4), a food is deemed to be adulterated if it has been held under insanitary conditions whereby it may have been rendered injurious to health.
 
Specifically, our investigation revealed that on or about October 10, 2014, you sold a cow, identified with ear tag (b)(4) 6345-8655 for slaughter as food. On or about October 10, 2014, (b)(4), slaughtered this animal. United States Department of Agriculture, Food Safety and Inspection Service (USDA/FSIS) analysis of tissue samples collected from this animal identified the presence of 0.054 parts per million (ppm) of penicillin in the kidney. FDA has established a tolerance of 0.05 ppm for residues of penicillin in the uncooked edible tissues of cattle as codified in Title 21, Code of Federal Regulations (C.F.R.), 556.510 (21 C.F.R. 556.510). The presence of this drug in uncooked edible tissue from this animal in this amount causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) of the FD&C Act, 21 U.S.C. § 342(a)(2)(C)(ii).
 
Our investigations also revealed that on April 1, 2009, you provided (b)(4), a signed certification stating that the livestock you sell do not have illegal levels of drug residues. According to the certificate, it remains in effect until the undersigned delivers written notice of revocation to (b)(4) . On October 10, 2014, you delivered a cow identified with ear tag (b)(4) , which contained violative residue of penicillin to (b)(4). Providing such a false guaranty is prohibited by section 301(h) of the FD&C Act, 21 U.S.C. § 331(h). You should take appropriate actions to ensure that this violation does not recur.
 
The above is not intended to be an all-inclusive list of violations. As a producer of animals offered for use as food, you are responsible for ensuring that your overall operation and the food you distribute is in compliance with the law. You should take prompt action to correct the violations described in this letter and to establish procedures to ensure that these violations do not recur. Failure to do so may result in regulatory action without further notice such as seizure and/or injunction. 
 
You should notify this office in writing of the steps you have taken to bring your firm into compliance with the law within fifteen (15) working days of receiving this letter. Your response should include each step that has been taken or will be taken to correct the violations and prevent their recurrence. If corrective action cannot be completed within fifteen (15) working days of receiving this letter, state the reason for the delay and the time frame within which the corrections will be completed. Please include copies of any available documentation demonstrating that corrections have been made.
 
Your written response should be sent to Jeff R. Wooley, Compliance Officer, U.S. Food and Drug Administration, 4040 N. Central Expressway, Suite 300, Dallas, Texas 75204. If you have any questions about this letter, please contact Compliance Officer Jeff R. Wooley at 214-253-5251.
 
 
Sincerely,
/S/
Reynaldo R. Rodriguez, Jr.
District Director
 
  
cc:    Dr. Steven D. Lewis, D.V.M
         P.O. Box 1756
         Hereford, TX 79045
 
         FSIS District Office 40
         Attn: Dr. Jennifer Beasley-McKean, DM
         1100 Commerce Street, Room 516
         Dallas, TX 75242-0598
 
         Texas Department of State Health Services
         1100 W. 49th Street
         Austin, TX 78756